Ledger.Open graph →
SEC Form D · filed May 10, 2019

LSK BioPartners, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Sung Chul Kim · Salt Lake City, UTExec · DirectorHa Young Kim · Salt Lake City, UTDirectorAnton Gueth · Salt Lake City, UTDirectorSoo Whan Choi · Salt Lake City, UTExec · DirectorAlex Kim · Salt Lake City, UTDirectorSung Chul Kim · Salt Lake City, UTExec · DirectorHa Young Kim · Salt Lake City, UTDirectorAnton Gueth · Salt Lake City, UTDirectorSoo Whan Choi · Salt Lake City, UTExec · DirectorAlex Kim · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗